Written Question on HIV Infection: Drugs

Written Questions are submitted by MPs or Lords to receive information from a Department.

See more on: "HIV Infection: Drugs"
Date Title Questioner
4 Oct 2019, 12:02 p.m. HIV Infection: Drugs Ms Lyn Brown


To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of the absence of additional funding for local authorities in connection with each additional local place in the PrEP Impact Trial on the (a) rate of increase of places available within the trial, (b) likelihood of meeting the target to double trial places and (c) likelihood of individuals seeking PrEP treatment not being able to access it over the next year.

Answer (Jo Churchill)

Following My Rt. hon. Friend the Secretary of State for Health and Social Care’s announcement on 30 January that the number of places on the Pre-Exposure Prophylaxis (PrEP) Impact Trial would be doubled to 26,000, expansion of the trial is now underway across the country.

Participation by sites in the trial is on a voluntary basis and it is for clinics and local authorities to decide the number of allocated places they can accept from the number offered. Around 85% of participating clinics have confirmed they have the capacity to accept additional trial places, and those places have been released. Local authorities have now been asked to confirm whether clinic service providers can accept the remaining places allocated to them. Places remaining un-allocated may then be re-allocated to clinics currently closed for recruitment.

You may also be interested in: